Cupid shares surged 7% after entering the Nifty Smallcap 250 index, extending gains to 16% in two sessions. The company has raised FY27 revenue and profit guidance following strong quarterly growth. Nuvama estimates around $10 million in potential inflows, while Cupid targets continued expansion across healthcare exports and consumer businesses.
Molbio Diagnostics shares rally 9% as Jefferies initiates ‘high conviction top pick’ call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600
September 30, 2026